Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: A population-based nationwide study

Liver International

Volumn 28, Issue 10, 2008, Pages 1389-1395

  Baatarkhuu, Oidov ^a,b   Kim, Do Young ^a   Ahn, Sang Hoon ^a   Nymadawa, Pagvajav ^c   Dahgwahdorj, Yagaanbuyant ^b   Shagdarsuren, Manaljav ^d   Park, Jun Yong ^a   Choi, Jong Won ^a   Oyunbileg, Janchiv ^e   Oyunsuren, Tsendsuren ^f   Han, Kwang Hyub ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Health Sciences University   (Mongolia)

^c National Center for Communicable Diseases   (Mongolia)

^d Shagdarsuren Clinical Hospital   (Mongolia)

^e Public Health Institute   (Mongolia)

^f The Institute of Biology   (Mongolia)

Author keywords

Genotype; HC VRNA; Hepatitis C virus; Mongolia; Prevalence

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MONGOLIA; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIRUS DETECTION;

AGE FACTORS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MONGOLIA; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 54049100382     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01820.x     Document Type: Article

References (24)

1. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44 (Suppl.): S6-9.
2. Limburg W. Natural history, treatment and prevention of hepatitis C in injecting drug users: An overview. In: Jager JC, Limburg W, Kretzschmar M, Postma MJ, Wiessing L, eds. Hepatitis C and Injecting Drug Use: Impact, Costs and Policy Options. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, 2004; 21-40.
3. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15: 5-14.
4. Mansell CT, Locarnini SA. Epidemiology of hepatitis C in the East. Semin Liver Dis 1995; 15: 15-32.
5. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-91.
6. Alter HJ, Houghton M. Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med 2000; 6: 1082-6.
7. Crofts N, Jolley D, van Kaldor JBI, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 1997; 51: 692-7.
8. Mongolian National Statistical Office Bulletin December 2006. http://202.131.5.91/bulletin_2006_dec.pdf
9. World Health Organization. The Work of WHO in the Western Pacific Region 2003-2004. Report of the Regional Director to the Regional Committee for the Western Pacific, Statistical Annex. Manila, Philippines: World Health Organization, Regional Office for the Western Pacific, 2003; 190-205.
10. Mongolia Today/Country briefs. http://www.mongoliatoday.com/info/ country_briefs.html
11. Okamoto H, Mishirio S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/ 1b with that of genotype III/2a or I/1a. Hepatology 1994; 20: 1131-6.
12. Okamoto H, Tokita H, Sakamoto M, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 2385-90.
13. Okamoto H, Kobata S, Tokita H, et al. A second-generation method of genotyping hepatitis C virus by the polymeraze chain reaction with sense and antisense primers deduced from the core gene. J Virol Methods 1996; 57: 31-45.
14. Cohen J. The scientific challenge of hepatitis C. Science 1999; 285: 26-30.
15. Stark K, Poggensee G, Hohne M, Bienzle U, Kiwelu I, Schreier E. Seroepidemiology of TT virus, GBV-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania. J Med Virol 2000; 62: 524-30.
16. Lvov DK, Samokhvalov EI, Tsuda F, et al. Prevalence of hepatitis C virus and distribution of its genotypes in Northern Euroasia. Arch Virol 1996; 141: 1613-22.
17. Oyunsuren Ts, Togos S, Odgerel Z. Prevalence of HBV and HCV infections in population of Ulaanbaatar. Mongolian Med Sci 1996; 4: 17-20.
18. Takahashi M, Nishizawa T, Gotanda Y, et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 2004; 11: 392-8.
19. Tsatsralt-Od B, Takahashi M, Nishizawa T, Unae J, Ulaankhuu D, Okamoto H. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 2005; 150: 2513-28.
20. Davaalkham D, Ojima T, Nymadawa P, et al. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a nationwide survey. J Med Virol 2006; 78: 466-72.
21. Ebright JR, Altantsetseg T, Oyungerel R. Emerging infectious diseases in Mongolia. Emerg Infect Dis 2003; 9: 1509-15.
22. Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330: 744-50.
23. National Statistical Office of Mongolia. Mongolian Population in XX Century. Ulaanbaatar: National Statistical Office of Mongolia, 2003; 365-75.
24. Lorvick J, Kral AH, Seal K, Gee L, Edlin BR. Prevalence and duration of hepatitis C among drug users in San Francisco, Calif. Am J Public Health 2001; 91: 46-47.